Skip to main content

CORRECTION article

Front. Cell Dev. Biol., 29 June 2021
Sec. Molecular and Cellular Pathology
Volume 9 - 2021 | https://doi.org/10.3389/fcell.2021.711764

Corrigendum: An MRTF-A–Sp1–PDE5 Axis Mediates Angiotensin-II-Induced Cardiomyocyte Hypertrophy

This article is a correction to:

  1. An MRTF-A–Sp1–PDE5 Axis Mediates Angiotensin-II-Induced Cardiomyocyte Hypertrophy

    1. Read original article
\nTeng WuTeng Wu1Huidi WangHuidi Wang1Xiaojun XinXiaojun Xin3Tianyi ZhangTianyi Zhang1Jie YangJie Yang1Yannan HouYannan Hou1Mingming Fang, Mingming Fang2,4*Xiang Lu Xiang Lu3*Yong Xu, Yong Xu1,4*
  • 1Key Laboratory of Targeted Intervention of Cardiovascular Disease and Collaborative Innovation Center for Cardiovascular Translational Medicine, Department of Pathophysiology, Nanjing Medical University, Nanjing, China
  • 2Laboratory Center for Experimental Medicine, Department of Clinical Medicine, Jiangsu Health Vocational College, Nanjing, China
  • 3Department of Geriatrics, Sir Run Run Hospital, Nanjing Medical University, Nanjing, China
  • 4Institute of Biomedical Research, Liaocheng University, Liaocheng, China

A Corrigendum on
An MRTF-A–Sp1–PDE5 Axis Mediates Angiotensin-II-Induced Cardiomyocyte Hypertrophy

by Wu, T., Wang, H., Xin, X., Zhang, T., Yang, J., Hou, Y., et al. (2020). Front. Cell Dev. Biol. 8:839. doi: 10.3389/fcell.2020.00839

Tianyi Zhang was not included as an author in the published article. The corrected Author Contributions Statement appears below.

“YX and TW conceived the project, designed the experiments, and wrote the manuscript. TW, HW, XX, TZ, JY, and YH performed experiments and collected data. MF and XL secured funding and provided supervision. All authors contributed to the article and approved the submitted version.”

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Keywords: cardiac hypertrophy, cardiomyocyte, transcriptional regulation, angiotensin II, MRTF-A, Sp1, PDE5

Citation: Wu T, Wang H, Xin X, Zhang T, Yang J, Hou Y, Fang M, Lu X and Xu Y (2021) Corrigendum: An MRTF-A–Sp1–PDE5 Axis Mediates Angiotensin-II-Induced Cardiomyocyte Hypertrophy. Front. Cell Dev. Biol. 9:711764. doi: 10.3389/fcell.2021.711764

Received: 19 May 2021; Accepted: 26 May 2021;
Published: 29 June 2021.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2021 Wu, Wang, Xin, Zhang, Yang, Hou, Fang, Lu and Xu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Mingming Fang, dafeifang@163.com; Xiang Lu, luxiang66@njmu.edu.cn; Yong Xu, yjxu@njmu.edu.cn

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.